Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with FAB/LMB-based chemotherapy regimen with rituximab.

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
11 Jul 2024
Historique:
received: 03 03 2024
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 11 7 2024
Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2024.285403 PMID: 38988265
pubmed: 38988265
doi: 10.3324/haematol.2024.285403
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Marie Emilie Dourthe (ME)

Department of Pediatric Hematology and Immunology, Robert Debré University Hospital, AP-HP and University de Paris, Paris, France; Université Paris Cité, Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, Paris. dourthe@aphp.fr.

Anne Auperin (A)

Service de Biostatistique et d'Epidémiologie, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif.

Charlotte Rigaud (C)

Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif.

Melissa Barbati (M)

Department of Pediatric Oncology and Haematology, University Hospital of Lille, Lille.

Jacinthe Bonneau (J)

Department of Pediatric Oncology and Haematology, University Hospital of Rennes, Rennes.

Nimrod Buchbinder (N)

Department of Pediatric Oncology and Haematology, University Hospital of Rouen, Rouen.

Marie-Laure Couec (ML)

Pediatric hematology and oncology department, University Hospital of Nantes, Nantes.

Peggy Dartigues (P)

Department of Biopathology, Morphology Unit, Gustave Roussy, Université Paris Saclay, Villejuif.

Stéphane Ducassou (S)

Department of Pediatric Oncology and Haematology, University Hospital of Bordeaux, Bordeaux.

Nathalie Garnier (N)

Institut d'Hématologie et d'Oncologie Pédiatrique, Hospices Civils de Lyon, Lyon.

Stéphanie Haouy (S)

Department of Pediatric Oncology and Haematology, University Hospital of Montpellier, Montpellier.

Bénédicte Jonca (B)

Department of nuclear medicine, University Hospital Tenon, Paris.

Anne Jourdain (A)

Department of Pediatric Oncology and Haematology, University Hospital of Tours, Tours.

Amaury Leruste (A)

SIREDO Oncology Center, Institut Curie, PSL Research University, Paris.

Thierry Molina (T)

Department of biopathology, University Hospital Necker Enfants Malades, Université Paris Cité, Paris.

Françoise Montravers (F)

Department of nuclear medicine, University Hospital Tenon, Paris.

Marlène Pasquet (M)

Department of Pediatric Oncology and Haematology, University Hospital of Toulouse, Toulouse.

Aurélie Phulpin (A)

Pediatric Oncology and Hematology Department, University Hospital of Nancy (CHRU Nancy), Nancy.

Maryline Poirée (M)

Department of Pediatric Oncology and Haematology, University Hospital of Nice, Nice.

Mathieu Simonin (M)

Pediatric Hematology Oncology Department, Sorbonne Université/Trousseau Hospital, APHP, Paris.

Alexandra Spiegel (A)

Pediatric Hematology Oncology Department, University Hospital of Strasbourg, Strasbourg.

Arnauld Verschuur (A)

Department of Pediatric Hematology Immunology and Oncology, La Timone Hospital, APHM, Marseille.

Thierry Leblanc (T)

Department of Pediatric Hematology and Immunology, Robert Debré University Hospital, AP-HP and University de Paris, Paris.

Judith Landman-Parker (J)

Pediatric Hematology Oncology Department, Sorbonne Université/Trousseau Hospital, APHP, Paris.

Catherine Patte (C)

Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif.

Véronique Minard-Colin (V)

Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; INSERM Unité 1015. veronique.minard@gustaveroussy.fr.

Classifications MeSH